Junshi Biosciences

Tip Ranks · 1 day ago, 06:09 AM

Junshi Biosciences Shareholders Approve H-Share Buyback Mandate

Tip Ranks · Jul 22 at 08:08 AM

Junshi Biosciences Completes RMB300 Million Technology Innovation Bond Issuance

Unusual Whales · Jul 21 at 06:12 PM

Junshi Biosciences Announces Acceptance of the Supplemental Application for Toripalimab plus Chemotherapy as Perioperative Treatment for Resectable Stage Ⅱ-Ⅲ NSCLC

Tip Ranks · Jul 21 at 09:09 AM

Junshi Biosciences Wins NMPA Nod to Expand Toripalimab Use in Early-Stage Lung Cancer

PUBT · Jul 21 at 08:23 AM

Shanghai Junshi says China regulator accepts label expansion filing for toripalimab chemo in resectable stage II-III NSCLC

Tip Ranks · Jul 8 at 09:38 AM

Junshi Biosciences Calls EGM to Seek Mandate for H-Share Buyback